Harvard Bioscience (NASDAQ: HBIO)
Harvard Bioscience Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Harvard Bioscience Company Info
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
News & Analysis
Harvard Bioscience Tops Q2 Revenue Views
Why Harvard Bioscience Stock Rose This Week
The company reported improved revenue in Q1.
I’m Selling Harvard Biosciences
This special situation played out reasonably well.
Why Harvard Bioscience Is Poised to Pop
Market-trouncing returns could be written in this 5-Star.
I'm Putting Real Money on Harvard Bioscience
This microcap is cheap.
Here's How Harvard Bioscience May Be Failing You
Keep your eye on margins.
5-Star Stocks Poised to Pop: Harvard Bioscience
Market-trouncing returns could be written in these five stars.
Tomorrow's Monster Stock?
A list of promising companies chosen by investors who've already picked stocks that beat the market with huge gains.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.